The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Naftopidil Tablets Market Research Report 2024

Global Naftopidil Tablets Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1742524

No of Pages : 99

Ask Your Query

Synopsis
Naftopidil is an α-receptor antagonist, which can relieve the sympathetic tension of the prostate and urethra by blocking adrenaline α1 receptors, reduce urethral pressure, and improve urination disorders caused by benign prostatic hyperplasia, etc. symptom.

Global Naftopidil Tablets market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Naftopidil Tablets market research.

Key manufacturers engaged in the Naftopidil Tablets industry include Asahi Kasei Corporation, Beijing SL Pharmaceutical Co.,Ltd., Hubei Qianjiang Pharmaceutical Co., Ltd., Shanghai Shyndec Pharmaceutical Co., Ltd., Hainan Simcere Pharmaceutical Co., Ltd., Bengbu Fengyuan Pharmaceutical Co., Ltd., GUIZHOU-EAKAN Pharmaceutical Co., Ltd., Tonghua Jitong Medical Co., Ltd. and Nanjing Meirui Pharma Co., Ltd., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Naftopidil Tablets were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Naftopidil Tablets market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Naftopidil Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Asahi Kasei Corporation
  • Beijing SL Pharmaceutical Co.,Ltd.
  • Hubei Qianjiang Pharmaceutical Co., Ltd.
  • Shanghai Shyndec Pharmaceutical Co., Ltd.
  • Hainan Simcere Pharmaceutical Co., Ltd.
  • Bengbu Fengyuan Pharmaceutical Co., Ltd.
  • GUIZHOU-EAKAN Pharmaceutical Co., Ltd.
  • Tonghua Jitong Medical Co., Ltd.
  • Nanjing Meirui Pharma Co., Ltd.
  • Shenzhen Neptunus Pharmaceutical Co., Ltd.

Segment by Type

  • 25mg/tablet
  • 50mg/tablet

Segment by Application

  • Hospital
  • Retail Pharmacy
  • Clinic
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Naftopidil Tablets report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Naftopidil Tablets Market Overview
1.1 Product Overview and Scope of Naftopidil Tablets
1.2 Naftopidil Tablets Segment by Type
1.2.1 Global Naftopidil Tablets Market Value Comparison by Type (2023-2029)
1.2.2 25mg/tablet
1.2.3 50mg/tablet
1.3 Naftopidil Tablets Segment by Application
1.3.1 Global Naftopidil Tablets Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Clinic
1.3.5 Others
1.4 Global Naftopidil Tablets Market Size Estimates and Forecasts
1.4.1 Global Naftopidil Tablets Revenue 2018-2029
1.4.2 Global Naftopidil Tablets Sales 2018-2029
1.4.3 Global Naftopidil Tablets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Naftopidil Tablets Market Competition by Manufacturers
2.1 Global Naftopidil Tablets Sales Market Share by Manufacturers (2018-2023)
2.2 Global Naftopidil Tablets Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Naftopidil Tablets Average Price by Manufacturers (2018-2023)
2.4 Global Naftopidil Tablets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Naftopidil Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Naftopidil Tablets, Product Type & Application
2.7 Naftopidil Tablets Market Competitive Situation and Trends
2.7.1 Naftopidil Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Naftopidil Tablets Players Market Share by Revenue
2.7.3 Global Naftopidil Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Naftopidil Tablets Retrospective Market Scenario by Region
3.1 Global Naftopidil Tablets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Naftopidil Tablets Global Naftopidil Tablets Sales by Region: 2018-2029
3.2.1 Global Naftopidil Tablets Sales by Region: 2018-2023
3.2.2 Global Naftopidil Tablets Sales by Region: 2024-2029
3.3 Global Naftopidil Tablets Global Naftopidil Tablets Revenue by Region: 2018-2029
3.3.1 Global Naftopidil Tablets Revenue by Region: 2018-2023
3.3.2 Global Naftopidil Tablets Revenue by Region: 2024-2029
3.4 North America Naftopidil Tablets Market Facts & Figures by Country
3.4.1 North America Naftopidil Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Naftopidil Tablets Sales by Country (2018-2029)
3.4.3 North America Naftopidil Tablets Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Naftopidil Tablets Market Facts & Figures by Country
3.5.1 Europe Naftopidil Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Naftopidil Tablets Sales by Country (2018-2029)
3.5.3 Europe Naftopidil Tablets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Naftopidil Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Naftopidil Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Naftopidil Tablets Sales by Country (2018-2029)
3.6.3 Asia Pacific Naftopidil Tablets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Naftopidil Tablets Market Facts & Figures by Country
3.7.1 Latin America Naftopidil Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Naftopidil Tablets Sales by Country (2018-2029)
3.7.3 Latin America Naftopidil Tablets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Naftopidil Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Naftopidil Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Naftopidil Tablets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Naftopidil Tablets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Naftopidil Tablets Sales by Type (2018-2029)
4.1.1 Global Naftopidil Tablets Sales by Type (2018-2023)
4.1.2 Global Naftopidil Tablets Sales by Type (2024-2029)
4.1.3 Global Naftopidil Tablets Sales Market Share by Type (2018-2029)
4.2 Global Naftopidil Tablets Revenue by Type (2018-2029)
4.2.1 Global Naftopidil Tablets Revenue by Type (2018-2023)
4.2.2 Global Naftopidil Tablets Revenue by Type (2024-2029)
4.2.3 Global Naftopidil Tablets Revenue Market Share by Type (2018-2029)
4.3 Global Naftopidil Tablets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Naftopidil Tablets Sales by Application (2018-2029)
5.1.1 Global Naftopidil Tablets Sales by Application (2018-2023)
5.1.2 Global Naftopidil Tablets Sales by Application (2024-2029)
5.1.3 Global Naftopidil Tablets Sales Market Share by Application (2018-2029)
5.2 Global Naftopidil Tablets Revenue by Application (2018-2029)
5.2.1 Global Naftopidil Tablets Revenue by Application (2018-2023)
5.2.2 Global Naftopidil Tablets Revenue by Application (2024-2029)
5.2.3 Global Naftopidil Tablets Revenue Market Share by Application (2018-2029)
5.3 Global Naftopidil Tablets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Asahi Kasei Corporation
6.1.1 Asahi Kasei Corporation Corporation Information
6.1.2 Asahi Kasei Corporation Description and Business Overview
6.1.3 Asahi Kasei Corporation Naftopidil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Asahi Kasei Corporation Naftopidil Tablets Product Portfolio
6.1.5 Asahi Kasei Corporation Recent Developments/Updates
6.2 Beijing SL Pharmaceutical Co.,Ltd.
6.2.1 Beijing SL Pharmaceutical Co.,Ltd. Corporation Information
6.2.2 Beijing SL Pharmaceutical Co.,Ltd. Description and Business Overview
6.2.3 Beijing SL Pharmaceutical Co.,Ltd. Naftopidil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Beijing SL Pharmaceutical Co.,Ltd. Naftopidil Tablets Product Portfolio
6.2.5 Beijing SL Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.3 Hubei Qianjiang Pharmaceutical Co., Ltd.
6.3.1 Hubei Qianjiang Pharmaceutical Co., Ltd. Corporation Information
6.3.2 Hubei Qianjiang Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Hubei Qianjiang Pharmaceutical Co., Ltd. Naftopidil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Hubei Qianjiang Pharmaceutical Co., Ltd. Naftopidil Tablets Product Portfolio
6.3.5 Hubei Qianjiang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Shanghai Shyndec Pharmaceutical Co., Ltd.
6.4.1 Shanghai Shyndec Pharmaceutical Co., Ltd. Corporation Information
6.4.2 Shanghai Shyndec Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Shanghai Shyndec Pharmaceutical Co., Ltd. Naftopidil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shanghai Shyndec Pharmaceutical Co., Ltd. Naftopidil Tablets Product Portfolio
6.4.5 Shanghai Shyndec Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Hainan Simcere Pharmaceutical Co., Ltd.
6.5.1 Hainan Simcere Pharmaceutical Co., Ltd. Corporation Information
6.5.2 Hainan Simcere Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Hainan Simcere Pharmaceutical Co., Ltd. Naftopidil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Hainan Simcere Pharmaceutical Co., Ltd. Naftopidil Tablets Product Portfolio
6.5.5 Hainan Simcere Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Bengbu Fengyuan Pharmaceutical Co., Ltd.
6.6.1 Bengbu Fengyuan Pharmaceutical Co., Ltd. Corporation Information
6.6.2 Bengbu Fengyuan Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Bengbu Fengyuan Pharmaceutical Co., Ltd. Naftopidil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Bengbu Fengyuan Pharmaceutical Co., Ltd. Naftopidil Tablets Product Portfolio
6.6.5 Bengbu Fengyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
6.7 GUIZHOU-EAKAN Pharmaceutical Co., Ltd.
6.6.1 GUIZHOU-EAKAN Pharmaceutical Co., Ltd. Corporation Information
6.6.2 GUIZHOU-EAKAN Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 GUIZHOU-EAKAN Pharmaceutical Co., Ltd. Naftopidil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GUIZHOU-EAKAN Pharmaceutical Co., Ltd. Naftopidil Tablets Product Portfolio
6.7.5 GUIZHOU-EAKAN Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Tonghua Jitong Medical Co., Ltd.
6.8.1 Tonghua Jitong Medical Co., Ltd. Corporation Information
6.8.2 Tonghua Jitong Medical Co., Ltd. Description and Business Overview
6.8.3 Tonghua Jitong Medical Co., Ltd. Naftopidil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Tonghua Jitong Medical Co., Ltd. Naftopidil Tablets Product Portfolio
6.8.5 Tonghua Jitong Medical Co., Ltd. Recent Developments/Updates
6.9 Nanjing Meirui Pharma Co., Ltd.
6.9.1 Nanjing Meirui Pharma Co., Ltd. Corporation Information
6.9.2 Nanjing Meirui Pharma Co., Ltd. Description and Business Overview
6.9.3 Nanjing Meirui Pharma Co., Ltd. Naftopidil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Nanjing Meirui Pharma Co., Ltd. Naftopidil Tablets Product Portfolio
6.9.5 Nanjing Meirui Pharma Co., Ltd. Recent Developments/Updates
6.10 Shenzhen Neptunus Pharmaceutical Co., Ltd.
6.10.1 Shenzhen Neptunus Pharmaceutical Co., Ltd. Corporation Information
6.10.2 Shenzhen Neptunus Pharmaceutical Co., Ltd. Description and Business Overview
6.10.3 Shenzhen Neptunus Pharmaceutical Co., Ltd. Naftopidil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Shenzhen Neptunus Pharmaceutical Co., Ltd. Naftopidil Tablets Product Portfolio
6.10.5 Shenzhen Neptunus Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Naftopidil Tablets Industry Chain Analysis
7.2 Naftopidil Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Naftopidil Tablets Production Mode & Process
7.4 Naftopidil Tablets Sales and Marketing
7.4.1 Naftopidil Tablets Sales Channels
7.4.2 Naftopidil Tablets Distributors
7.5 Naftopidil Tablets Customers
8 Naftopidil Tablets Market Dynamics
8.1 Naftopidil Tablets Industry Trends
8.2 Naftopidil Tablets Market Drivers
8.3 Naftopidil Tablets Market Challenges
8.4 Naftopidil Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock